MURINE T-HELPER CELL-2 LYMPHOCYTES EXPRESS TYPE-I AND TYPE-II IL-1 RECEPTORS, BUT ONLY THE TYPE-I RECEPTOR MEDIATES COSTIMULATORY ACTIVITY

被引:0
|
作者
MCKEAN, DJ
PODZORSKI, RP
BELL, MP
NILSON, AE
HUNTOON, CJ
SLACK, J
DOWER, SK
SIMS, J
机构
[1] IMMUNEX RES & DEV CORP,DEPT MOLEC BIOL,SEATTLE,WA 98101
[2] IMMUNEX RES & DEV CORP,DEPT BIOCHEM,SEATTLE,WA 98101
来源
JOURNAL OF IMMUNOLOGY | 1993年 / 151卷 / 07期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of IL-1 in augmenting the Ag receptor-initiate activation program was evaluated in IL-4-producing (Th2) CD4+ murine T lymphocytes. Northern blot and I-125-labeled IL-1alpha cross-linking analyses demonstrated that Th2 lymphocytes express both type I and type II IL-1R. The expression of both IL-1R isoforms on the surface of the Th2 cells is coordinately up-regulated in response to anti-CD3 cross-linking in the absence of detectable accessory cells. Analyses of the kinetics of IL-1R acquisition demonstrated that the peak level of type I and type II IL-1R mRNA expression occurs after the peak expression of mRNA encoding IL-2Ralpha and IL-4, which are two IL-1-responsive events in the Th2 activation program. Type I IL-1 R ligand-binding antagonists, IL-1R antagonist and anti-type I mAb, were used to evaluate the functional significance of Th2 cell expression of two IL-1R isoforms. The addition of either IL-1R antagonist or anti-type I mAb completely inhibited the IL-1alpha-augmented component of the proliferative response stimulated by anti-CD3 plus exogenous IL-1alpha. Together, these studies indicate that, although Th2 clones express inducible levels of both type I and type II IL-1R isoforms, the IL-1-induced intracellular signals involved in augmenting an anti-CD3-stimulated proliferative response are mediated solely through the type I IL-1R.
引用
收藏
页码:3500 / 3510
页数:11
相关论文
共 50 条
  • [31] Soluble type-I interleukin-1 receptor blocks chicken IL-1 activity
    Klasing, KC
    Peng, RK
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2001, 25 (04): : 345 - 352
  • [32] EXPRESSION OF TYPE-I AND TYPE-II INTERLEUKIN-1 RECEPTORS IN MOUSE-BRAIN
    PARNET, P
    AMINDARI, S
    WU, C
    BRUNKEREESE, D
    GOUJON, E
    WEYHENMEYER, JA
    DANTZER, R
    KELLEY, KW
    MOLECULAR BRAIN RESEARCH, 1994, 27 (01): : 63 - 70
  • [33] ISOLATED RABBIT TYPE-II CELLS HAVE TYPE-I AND TYPE-II RECEPTORS FOR TGF-BETA
    RYAN, RM
    MINEOKUHN, MM
    FINKELSTEIN, JN
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A159 - A159
  • [34] LINKAGE ANALYSIS OF BOVINE INTERLEUKIN-1 RECEPTOR TYPE-I AND TYPE-II (IL-1R-I, IL-1R-II)
    YOO, J
    STONE, RT
    KAPPES, SM
    BEATTIE, CW
    MAMMALIAN GENOME, 1994, 5 (12) : 820 - 821
  • [35] THE EPIDEMIOLOGY OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II
    KAPLAN, JE
    KHABBAZ, RF
    REVIEWS IN MEDICAL VIROLOGY, 1993, 3 (03) : 137 - 148
  • [36] BIOLOGIC ACTIVITY OF TYPE-I AND TYPE-II FUSOBACTERIUM-NUCLEATUM COLONIES
    MONTOYA, R
    VINCENT, JW
    CORNETT, W
    FALKLER, WA
    JOURNAL OF DENTAL RESEARCH, 1984, 63 : 305 - 305
  • [37] SYNERGISTIC ACTIVITIES OF TYPE-I (ALPHA, BETA) AND TYPE-II (GAMMA) MURINE INTERFERONS
    ZERIAL, A
    HOVANESSIAN, AG
    STEFANOS, S
    HUYGEN, K
    WERNER, GH
    FALCOFF, E
    ANTIVIRAL RESEARCH, 1982, 2 (04) : 227 - 239
  • [38] SHARED ARCHITECTURE OF HORMONE BINDING DOMAINS IN TYPE-I AND TYPE-II INTERFERON RECEPTORS
    BAZAN, JF
    CELL, 1990, 61 (05) : 753 - 754
  • [39] DEMONSTRATION OF TYPE-I AND TYPE-II SOMATOMEDIN RECEPTORS ON BOVINE GROWTH PLATE CHONDROCYTES
    TRIPPEL, SB
    CHERNAUSEK, SD
    VANWYK, JJ
    MOSES, AC
    MANKIN, HJ
    JOURNAL OF ORTHOPAEDIC RESEARCH, 1988, 6 (06) : 817 - 826
  • [40] TYPE-I AND TYPE-II GABAA-BENZODIAZEPINE RECEPTORS PRODUCED IN TRANSFECTED CELLS
    PRITCHETT, DB
    LUDDENS, H
    SEEBURG, PH
    SCIENCE, 1989, 245 (4924) : 1389 - 1392